This article deals with a selection of books that I have chosen rigorously. They are not necessarily new ones, but still relevant books that we use as CRA or Study Coordinator. Generally, these books have changed my point of view on biomedical research and the clinical research associate profession because they allowed me to see more clearly in my profession. These books are for everyone’s hands.
The “Famous” Dorosz Practical Drugs Guide 2015 34th edition
Not without my Dorosz!
Which experienced CRA or Site Study Coordinator does not know this essential work tool?
Two solutions:
- Either you’re lucky to have an employer who makes it available for your monitoring visits,
- Or you can get it yourself. When we want to be effective, we must acquire the resources 🙂
The Dorosz is updated with new drugs marketed brought every year. As far as I am concerned, I have the same for several years, no need to buy one every year. Sometimes you cannot find a newly marketed drug, if you do not have the latest version; you just have to search in the internet during your monitoring visit. This happens very rarely to me and my Dorosz is enough for me 🙂
Researching a treatment in Dorosz is a thousand times easier than in Vidal. In addition, it has the advantage of being in pocket version: you can slip it easily into your monitoring suitcase. Another argument: the Dorosz is cheaper than the Vidal 🙁 In short, the Dorosz is a Vidal in a better aspect 😉
Treatments are arranged alphabetically. Drugs are listed under their International Nonproprietary Name (INN) and under the trade names with their dispensation modality in France.
What is this book and how is it really used in monitoring visit:
In general, when you monitor a center, you have to check the various treatments taken by the patient in the source folder and the reasons why these treatments were made. Furthermore, you have to make sure that all adverse events reported in the CRF have been reported by the investigator. To do this task properly, it is important to check all treatments taken by the patient and make sure that these treatments correspond to an adverse event or that the treatment is taken prophylactically.
For example, if you see in the patient’s medical record that he took Ondansetron and if you do not know what is this molecule or treatment, you just have to search in your Dorosz. Then you will see that this is an antiemetic: obviously, the patient was vomiting.
Whether you are CRA or Site Study Coordinator, when you will see your investigator for clarification or requests for corrections in the CRF, you will be able to ask him about that. You’ll eventually ask to add information in the CRF as an adverse event and put add in the note that the patient was vomiting.
For me, this book is a must whether you are experienced or beginner CRA or Study Coordinator, you will be surprised how this book will help you. This book costs 65 euros. We all agree it is expensive. However, this is an essential tool for a monitoring of quality!
If you are interested in this book you’ll find it on Amazon, I have put a link below.
See you soon,
Vanessa Montanari